Contemporary OB/GYN week in review: mifepristone, cervical cancer, and more

News
Article

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

Contemporary OB/GYN week in review: mifepristone, cervical cancer, and more

Contemporary OB/GYN week in review: mifepristone, cervical cancer, and more

Thank you for visiting the Contemporary OB/GYN® website. Take a look at some of our top stories from last week (Monday, June 10 - Friday, June 14, 2024), and click each link to read and watch anything you may have missed.

1.) Supreme Court retains nationwide access to mifepristone

In a unanimous ruling, the Supreme Court rejected a challenge by antiabortion doctors, maintaining nationwide access to mifepristone for medication abortions and reversing a lower court's decision to restrict the pill's availability.

Click here for the full article.

2.) Guidelines released to boost cervical cancer screening in high-income countries

The ACCESS Consensus Group's new guidelines aim to enhance cervical cancer screening and reduce mortality rates in high-income countries, emphasizing the urgent need for increased participation and innovative approaches such as self-sampling.

Click here for the full article.

3.) Sex-based disparities for hospital quality linked to increased female mortality rate

A recent study reveals that female Medicare beneficiaries face a significant increase in mortality disparity compared to male beneficiaries, particularly at lower-quality hospitals, underscoring the need for equitable access to high-quality care.

Click here for the full article.

4.) Rising prevalence of hypertensive disorders of pregnancy reported

A recent study reveals a significant increase in hypertensive disorders among pregnant individuals in the United States from 2010 to 2021, highlighting the need for focused public health measures to mitigate modifiable risk factors.

Click here for the full article.

5.) Chronic kidney disease linked to tooth loss in postmenopausal women

A new study recently published in Menopause, the journal of The Menopause Society, suggests a significant link between chronic kidney disease (CKD) and tooth loss, particularly in postmenopausal women.

Click here for the full article.

Related Videos
One year out: Fezolinetant displays patient satisfaction for managing hot flashes | Image Credit: sutterhealth.org
Addressing maternal health inequities: Insights from CDC's Wanda Barfield | Image Credit: cdc.gov
Addressing racial and ethnic disparities in brachial plexus birth Injury | Image Credit: shrinerschildrens.org
Innovations in prenatal care: Insights from ACOG 2024 | Image Credit:  uofmhealth.org.
Unlocking therapeutic strategies for menopausal cognitive decline | Image Credit: uclahealth.org.
Navigating menopause care: Expert insights from ACOG 2024 | Image Credit: mayo.edu.
New data shows elinzanetant's efficacy in treating menopausal symptoms | Image Credit: uvahealth.com
Navigating vasomotor symptoms in breast cancer patients | Image Credit: menopausefoundationcanada.ca.
The impact of smoking cessation on pregnancy outcomes | Image Credit: rwjmg.rwjms.rutgers.edu
Related Content
© 2024 MJH Life Sciences

All rights reserved.